Andrew M. Kopelman

MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

Catherine M. Shachaf, Andrew M. Kopelman, Constadina Arvanitis et al. · Nature · 2004 · 869 citations

Tumor Biology, Oncology, Hepatocellular Cancer +9

Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch

Sylvie Giuriato, Sandra Ryeom, Alice C. Fan et al. · Proceedings of the National Academy of Sciences · 2006 · 146 citations · Full text

Immunology, Pathology, Targeted Inactivation +16

Requests for 692 Transfers to an Academic Level I Trauma Center: Implications of the Emergency Medical Treatment and Active Labor Act

David A. Spain, Michael J. Bellino, Andrew M. Kopelman et al. · The Journal of Trauma: Injury, Infection, and Critical Care · 2007 · 61 citations

CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation

Kavya Rakhra, Pavan Bachireddy, Tahera Zabuawala et al. · Cancer Cell · 2010 · 18 citations · Full text

Cancer Immunosurveillance, Microenvironment Required, T-regulatory Cell +9